GlassScriptPhysician profile
Drew M Locandro
NPI 1790786911
$6,015.53
in general payments reported to CMS, 2019-2025
21 companies · $847 in 2025
The $847 reported for 2025 was more than what 76% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $639 · 2020: $1,289 · 2021: $499 · 2022: $1,196 · 2023: $1,103 · 2024: $442 · 2025: $847.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,959 · Consulting Fee: $400 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,959.08 |
| Consulting Fee | $400.00 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $1,955.51 | 2019-2024 | |
| Genzyme Corporation | $792.09 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $687.28 | 2019-2025 | Dupixent |
| Glaxosmithkline, LLC. | $653.62 | 2021-2025 | Nucala |
| Optinose US, INC. | $569.12 | 2019-2025 | |
| Intersect Ent, INC. | $292.16 | 2019-2022 | |
| Alk-Abello, INC | $236.58 | 2019-2023 | Grastek, Ragwitek, Odactra |
| Integra Lifesciences Corporation | $150.00 | 2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Stryker Corporation | $141.81 | 2019-2025 | Scopis Ent |
| Kaleo, INC. | $115.03 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $111.29 | 2025 | Tezspire |
| Medtronic USA, INC. | $76.83 | 2019-2020 | |
| Amgen INC. | $71.33 | 2025 | Tezspire |
| Medtronic, INC. | $37.42 | 2021-2024 | Sinuva |
| Olympus America INC. | $31.77 | 2022-2023 | Rhino-Laryngo Videoscope |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Checkpoint Surgical, INC | $23.75 | 2019 | |
| Hikma Pharmaceuticals USA | $15.30 | 2022 | |
| Merck Sharp & Dohme LLC | $14.50 | 2023 | |
| Polynovo North America LLC | $14.40 | 2024 | Novosorb Btm |
| Neurent Medical Limited | $13.12 | 2023 | Neuromark Radiofrequency Console, Neuromark Device |
| Arbor Pharmaceuticals, INC. | $12.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Drew Locandro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.